Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.9B | 1.9B | 2.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 252M | 293M | 295M | 305M |
Other operating expenses | 216M | 8M | 116M | 8M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 450M | 1.0B | 1.0B | 1.1B |
Tax provision | 84M | 267M | 255M | 277M |
Net income | 366M | 772M | 763M | 861M |
Basic EPS | — | 14.3 | — | 15.5 |
Diluted EPS | — | 14.3 | — | 15.5 |
Basic average shares | — | 52.9M | — | 54.5M |
Diluted average shares | — | 52.9M | — | 54.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 450M | 1.0B | 1.0B | 1.1B |
Minority interests | — | -5M | -1M | -3M |
Preferred stock dividends | — | 10M | 9M | 10M |